Meribank Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	97.44	165.09	399.46	85.16	192.15
Short-Term Investments	131.9	-	-	122.7	94.1
Cash & Short-Term Investments	229.34	165.09	399.46	207.86	286.25
Cash Growth	38.92%	-58.67%	92.18%	-27.39%	194.21%
Accounts Receivable	192.87	158.22	128.63	146.97	147.53
Other Receivables	-	8.82	6.5	5.47	1.63
Receivables	192.87	167.04	135.13	152.44	149.17
Inventory	6.42	11.24	6.91	8.45	3.6
Prepaid Expenses	40.27	49.6	28.61	24.13	19.87
Other Current Assets	1.73	0.34	0.09	0.02	0.11
Total Current Assets	470.63	393.31	570.19	392.9	458.99
Property, Plant & Equipment	473.71	479.46	162.06	178.19	190.76
Long-Term Investments	39.13	59.57	59.56	25.22	44.45
Goodwill	-	282.18	2.87	-	-
Other Intangible Assets	828.32	584.09	31.69	10.22	1.09
Long-Term Deferred Tax Assets	4.26	3.8	2.48	-	-
Other Long-Term Assets	1,060	879.54	233.17	239.8	252.03
Total Assets	2,876	2,682	1,062	846.33	947.32
Accounts Payable	6.92	13.08	12.32	7.6	4.75
Accrued Expenses	-	53.9	50.63	45.84	44.57
Current Portion of Long-Term Debt	-	7.32	-	-	-
Current Portion of Leases	126.83	70.85	19.23	21.58	18.25
Current Unearned Revenue	22.47	27.33	17.56	14.76	12.97
Other Current Liabilities	91.34	59.76	27.17	19.28	15.34
Total Current Liabilities	247.55	232.23	126.91	109.07	95.87
Long-Term Debt	155.41	162.88	-	-	-
Long-Term Leases	837.96	701.79	14.81	24.25	34.73
Long-Term Unearned Revenue	261.98	258.41	245.7	236.52	228.14
Long-Term Deferred Tax Liabilities	93.51	99.83	1.38	0.65	-
Other Long-Term Liabilities	19.88	9.42	2.02	2.05	2.53
Total Liabilities	1,616	1,465	390.81	372.53	361.27
Common Stock	959.76	879.76	709.76	627.76	627.76
Additional Paid-In Capital	758.71	710.82	233.2	203.24	203.74
Retained Earnings	-454.7	-373.23	-272.2	-350.09	-247.58
Comprehensive Income & Other	-14.63	-11.62	-9.04	-9.71	2.12
Total Common Equity	1,249	1,206	661.73	471.2	586.05
Minority Interest	10.96	11.65	9.46	2.59	-
Shareholders' Equity	1,260	1,217	671.2	473.79	586.05
Total Liabilities & Equity	2,876	2,682	1,062	846.33	947.32
Total Debt	1,120	942.84	34.04	45.83	52.97
Net Cash (Debt)	-890.86	-777.75	365.42	162.03	233.28
Net Cash Growth	-	-	125.53%	-30.54%	752.06%
Net Cash Per Share	-9.73	-9.78	5.81	2.58	3.87
Filing Date Shares Outstanding	95.09	87.98	70.98	62.78	62.78
Total Common Shares Outstanding	95.09	87.98	70.98	62.78	62.78
Working Capital	223.08	161.08	443.27	283.83	363.12
Book Value Per Share	13.14	13.71	9.32	7.51	9.34
Tangible Book Value	420.83	339.46	627.17	460.98	584.96
Tangible Book Value Per Share	4.43	3.86	8.84	7.34	9.32
Land	-	214.7	41.08	41.08	41.08
Buildings	-	107.62	53.84	53.23	52.95
Machinery	-	96.57	76.56	61.45	62.83

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.